Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Nutr ; 20(4): 319-23, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11478829

RESUMEN

BACKGROUND AND AIMS: Animal studies have reported positive effects of glutamine on intestinal absorption and morphology; human studies have been less convincing. The aim of this study was to evaluate the effects of glutamine and diet on intestinal morphology, motility, and absorption. METHODS: A randomized, double blind, placebo-controlled crossover study in 8 patients with short-bowel on a high carbohydrate, low fat (HCLF) diet, was performed. Active treatment was oral glutamine (0.45 g kg(-1)day(-1)) for eight weeks. Intestinal morphology was evaluated by light microscopy. Gastrointestinal transit was measured by dual gamma camera scintigraphy. D-xylose and fecal fat collection was used to evaluate intestinal absorption. Results of active treatment versus placebo were compared by the signed-rank test. RESULTS: Morphology analysis, reported as median active treatment versus placebo, was villus height: 0.48 mm versus 0.50 mm, P=1.0, and crypt depth: 0.11 mm versus 0.10 mm, P=0.469. Percent D-xylose absorption, reported as median active treatment versus placebo, was 7% versus 10.5%, P=0.109. There was not a significant difference in wet weight or fat absorption compared to placebo, P>0.05. Likewise, gastrointestinal transit was not different compared to placebo. CONCLUSIONS: The results of this controlled study would support that 8 weeks of treatment with oral glutamine and a HCLF diet does not significantly improve intestinal morphology, gastrointestinal transit, D-xylose absorption and stool losses in short bowel patients.


Asunto(s)
Motilidad Gastrointestinal/efectos de los fármacos , Glutamina/farmacología , Absorción Intestinal/efectos de los fármacos , Intestinos/patología , Síndrome del Intestino Corto/tratamiento farmacológico , Xilosa/farmacocinética , Adulto , Anciano , Estudios Cruzados , Heces/química , Femenino , Tránsito Gastrointestinal , Humanos , Masculino , Persona de Mediana Edad , Síndrome del Intestino Corto/fisiopatología
2.
J Immunol ; 157(5): 2174-85, 1996 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-8757344

RESUMEN

We report here a murine model for experimental chronic colitis where administration of trinitrobenzene sulfonic acid (TNBS) in 50% ethanol induced inflammation of large intestine in susceptible (C3H/HeJ and BALB/c) but not resistant (C57BL/6 and DBA/2) mouse strains. We queried whether mucosal trinitrophenyl (TNP)-specific B cell responses were induced in mice with TNBS-induced colitis, and if induction of tolerance to TNBS by oral administration of this hapten protected mice from development of colitis. Isotypes and subclasses of polyclonal and TNP-specific Ab-forming cells (AFC) were assessed in mucosal and peripheral lymphoid tissues of C3H/HeJ mice with TNBS-induced colitis. Increased numbers of IgA- and IgG-secreting cells were found in the inflamed colon lamina propria. Inflamed colonic tissue also contained high frequencies of IgG anti-TNP AFC (predominantly of IgG1, IgG2a, and IgG2b subclasses); however, anti-TNP responses in noninflamed mucosal tissues of mice with colitis exhibited dominant IgA and IgM with low IgG anti-TNP responses. CD4+ T cells stimulated with TNP-splenocytes produced more IFN-gamma and less IL-4, suggesting a Th1-type response. Oral administration of TNBS before induction of colitis markedly decreased mucosal anti-TNP responses and completely inhibited anti-TNP IgG2a and IgG2b responses. Control mice did not show inhibition of anti-TNP AFC responses or TNBS-induced colitis. Intracolonic sensitization of susceptible C3H/HeJ mice with TNBS induces a localized IgG anti-TNP B cell response in the inflamed tissue, whereas prior oral administration of TNBS results in unresponsiveness to this agent and protects mice from development of TNBS-induced colitis.


Asunto(s)
Haptenos/inmunología , Tolerancia Inmunológica , Enfermedades Inflamatorias del Intestino/etiología , Enfermedades Inflamatorias del Intestino/prevención & control , Mucosa Intestinal/inmunología , Administración Oral , Administración Rectal , Animales , Formación de Anticuerpos , Linfocitos T CD4-Positivos/metabolismo , Citocinas/biosíntesis , Modelos Animales de Enfermedad , Epítopos/inmunología , Femenino , Haptenos/administración & dosificación , Inmunosupresores/toxicidad , Enfermedades Inflamatorias del Intestino/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Trinitrobencenos/inmunología , Ácido Trinitrobencenosulfónico/administración & dosificación , Ácido Trinitrobencenosulfónico/inmunología
3.
Arterioscler Thromb Vasc Biol ; 16(9): 1189-96, 1996 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8792774

RESUMEN

Mutations on the apolipoprotein (apo) B gene that interfere with the full-length translation of the apoB molecule are associated with familial hypobetalipoproteinemia (FHBL), a disease characterized by the reduction of plasma apoB and LDL cholesterol. In this report, we describe an FHBL kindred carrying a unique truncated apoB form, apoB-87Padova. Sequence analysis of amplified genomic DNA identified a single G deletion at nucleotide 12032, which shifts the translation reading frame and causes a termination at amino acid 3978. Two homozygous subjects and seven heterozygous relatives were studied. Although homozygous individuals had only trace amounts of LDL, they were virtually free from the symptoms typical of homozygous FHBL subjects. We investigated the in vivo turnover of radiolabeled normal apoB-100 LDL and apoB-87 LDL in one homozygous patient and two normal control subjects. ApoB-87 LDL showed a similar metabolism in all three subjects, with a fractional catabolic rate more than double that of normal LDL. The rate of entry of apoB-87 in the LDL compartment was also markedly decreased compared with normal apoB-100. The increased in vivo catabolism of apoB-87 LDL was paralleled in vitro by a 2.5-fold increased ability of these particles to inhibit the uptake and degradation of normal apoB-100 LDL by normal human cultured fibroblasts. These results indicate that apoB-87 LDL has an enhanced ability to interact with the LDL receptor, the increased apoB catabolism contributes to the hypobetalipoproteinemia and may explain the mild expression of the disease in the two homozygous individuals.


Asunto(s)
Apolipoproteínas B/metabolismo , Hipobetalipoproteinemias/genética , Adulto , Secuencia de Aminoácidos , Apolipoproteínas B/genética , Secuencia de Bases , Femenino , Homocigoto , Humanos , Hipobetalipoproteinemias/metabolismo , Datos de Secuencia Molecular , Linaje
4.
Am J Physiol ; 271(1 Pt 1): G130-6, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8760116

RESUMEN

The mechanisms of wound healing in the gut are poorly understood but are mediated by cytokines in other tissues. In this study we wanted to determine which cytokines were expressed after nonspecific colonic injury, the kinetics of that expression, and how cytokine expression correlated with tissue histology. At 0, 4, 8, 12, 24, 48, and 72 h after intrarectal administration of 3% acetic acid to C3H/HeJ mice, their colons were removed for histology, organ culture, and RNA extraction. Cytokine mRNA expression for various cytokines was assessed by reverse transcriptase-polymerase chain reaction with primers specific for each cytokine. Cytokine production in organ cultures was measured with bioassays. Shortly after colonic injury and during colonic regeneration, proinflammatory cytokines such as interleukin-1 beta (IL-1 beta), IL-6, tumor necrosis factor-alpha (TNF-alpha), macrophage inflammatory protein (MIP), and transforming growth factor-beta (TGF-beta) were expressed. In contrast, expression of T cell-derived cytokines was not detected at any time point. Cytokines such as IL-1 beta, IL-6, IL-10, TNF-alpha, and MIP-1 are important mediators of tissue repair and restitution after nonspecific colonic injury and may subserve a similar role in human colitis.


Asunto(s)
Colitis/fisiopatología , Citocinas/metabolismo , Cicatrización de Heridas/fisiología , Ácido Acético , Enfermedad Aguda , Animales , Secuencia de Bases , Línea Celular , Colitis/inducido químicamente , Colitis/patología , Citocinas/genética , Femenino , Cinética , Ratones , Ratones Endogámicos C3H , Sondas Moleculares , Datos de Secuencia Molecular , Técnicas de Cultivo de Órganos , ARN Mensajero/metabolismo , Factores de Tiempo
6.
Gastroenterology ; 107(6): 1643-52, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7958674

RESUMEN

BACKGROUND/AIMS: Oral administration of dextran sulfate sodium (DSS) has been reported to induce colitis in mice. The purpose of this study was to determine whether the possible pathogenic mechanism involved the acquired immune system. METHODS: Normal BALB/c and related C.B17 severe combined immunodeficient mice were fed 5% DSS (40 kilodaltons) in their drinking water for 7 days; controls were fed only water. Colons were scored for histological activity at various times. Cytokine production by cultures of colon and of draining lymph node cell was measured. The effect of DSS on the proliferation of the MCA-38 colonic epithelial cell line was assessed. RESULTS: DSS feeding resulted in a very reproducible acute distal colitis in both BALB/c and C.B17 severe combined immunodeficient mice. The lesions of BALB/c mice had an increased production of macrophage-derived cytokines, such as interleukin (IL) 1 beta, IL-6, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor, but not the T-cell cytokines IL-3 or interferon gamma. Draining lymph node cells produced these cytokines plus interferon gamma and IL-3. DSS inhibited MCA-38 cells at doses that would be easily achieved in the distal colon. CONCLUSIONS: Acute DSS-induced colitis does not require the presence of T cells or B cells because it occurred in C.B17 severe combined immunodeficient mice that lack these cells. Its induction may result from a toxicity of DSS for colonic epithelial cells.


Asunto(s)
Colitis/inducido químicamente , Sulfato de Dextran/efectos adversos , Enfermedad Aguda , Animales , División Celular/efectos de los fármacos , Células Cultivadas , Colitis/inmunología , Colitis/patología , Colon/efectos de los fármacos , Colon/inmunología , Colon/patología , Epitelio/efectos de los fármacos , Epitelio/patología , Femenino , Factor Estimulante de Colonias de Granulocitos y Macrófagos/biosíntesis , Inmunohistoquímica , Interferón gamma/biosíntesis , Interleucina-1/biosíntesis , Interleucina-3/biosíntesis , Interleucina-6/biosíntesis , Ganglios Linfáticos/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones SCID , Factor de Necrosis Tumoral alfa/biosíntesis
7.
Am J Pathol ; 145(5): 1168-74, 1994 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7977647

RESUMEN

Neurofibromatosis in cattle is typically a noncutaneous disease. A small group of cows in a Holstein dairy herd developed cutaneous neurofibromatosis. This unique condition was investigated and compared with neurofibromatosis type 1 (NF1) in humans. All cutaneous lesions but one were consistent with neurofibromas in noncutaneous sites in cattle and neurofibromas in patients with NF1. One bovine lesion was classified as a neurofibrosarcoma. Immunohistochemistry and electron microscopy supported Schwannian differentiation in benign and malignant lesions. Linkage analysis with a polymorphism in the bovine NF1 gene confirmed that two affected animals from the same sire inherited the same paternal NF1 allele. Bovine cutaneous neurofibromatosis is a naturally occurring disease in this group of animals, characterized by skin tumors morphologically identical to those of NF1. An informative polymorphism at the NF1 locus of two animals and their sire suggests this disorder may be caused by hereditary mutations at the bovine NF1 locus.


Asunto(s)
Enfermedades de los Bovinos/genética , Neurofibromatosis 1/veterinaria , Neoplasias Cutáneas/veterinaria , Animales , Southern Blotting , Bovinos , Enfermedades de los Bovinos/patología , ADN de Neoplasias/análisis , Femenino , Genes de Neurofibromatosis 1 , Ligamiento Genético , Humanos , Neurofibromatosis 1/genética , Neurofibromatosis 1/patología , Linaje , Polimorfismo Genético , Piel/ultraestructura , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología
8.
J Clin Invest ; 91(5): 2296-300, 1993 May.
Artículo en Inglés | MEDLINE | ID: mdl-8486789

RESUMEN

Thyroid hormone resistance (THR) is primarily an autosomal dominant inherited disease characterized by resistance of pituitary and peripheral tissues to the action of thyroid hormone. We investigated whether the heterogeneous phenotypic features that occur not only among kindreds but also within the same kindred might be due to the expression of differing ratios of mutant and normal receptors in tissues. Using an allele-specific primer extension method, we determined the relative expression of normal and mutant mRNAs from the fibroblasts of affected and unaffected members of two kindreds with TRH: A-H and N-N. While two affected members of A-H, as expected, had nearly equal amounts of normal and mutant hTR beta mRNA, two other members had mutant mRNA levels that accounted for at least 70% of the hTR beta mRNA. Phenotypic variability within and between kindreds with generalized resistance to thyroid hormone GRTH may be due to this differential expression of the mutant and wild type mRNA. Furthermore, when several clinical parameters of THR were compared in several affected members from two kindreds with GRTH, we found that two cases in one kindred exhibited a high mutant-to-normal hTR beta ratio and had considerably more bone resistance during their development. In certain kindreds with THR, differing ratios of normal and mutant hTR receptors may be age and growth related and may account for the reported attenuation of phenotypic symptoms with age.


Asunto(s)
Trastornos del Crecimiento/genética , Mutación , Receptores de Hormona Tiroidea/genética , Hormonas Tiroideas/uso terapéutico , Adolescente , Alelos , Secuencia de Bases , Estatura , Niño , ADN/genética , ADN/aislamiento & purificación , Resistencia a Medicamentos/genética , Femenino , Fibroblastos , Genes Dominantes , Trastornos del Crecimiento/fisiopatología , Humanos , Masculino , Datos de Secuencia Molecular , Oligodesoxirribonucleótidos , Linaje , Plásmidos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Piel/patología , Piel/fisiopatología
9.
Am J Gastroenterol ; 88(2): 289-92, 1993 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8424436

RESUMEN

We report an unusual presentation of gastroesophageal reflux disease in a 14-yr-old boy with cervical dysphagia and vomiting immediately after swallowing. Reflux disease was diagnosed by the combination of eosinophils on esophageal biopsies and abnormal 24-h pH results. The cervical site of dysphagia demonstrated acid-induced hypersensitivity to esophageal distension with water or air. The patient's symptoms resolved with marked acid suppression, which was made difficult because intact capsules of omeprazole initially could not be ingested.


Asunto(s)
Trastornos de Deglución/etiología , Reflujo Gastroesofágico/complicaciones , Vómitos/etiología , Adolescente , Nutrición Enteral , Eosinófilos/patología , Esofagitis Péptica/tratamiento farmacológico , Esofagitis Péptica/etiología , Esofagitis Péptica/patología , Esófago/patología , Estudios de Seguimiento , Reflujo Gastroesofágico/diagnóstico , Reflujo Gastroesofágico/tratamiento farmacológico , Reflujo Gastroesofágico/patología , Humanos , Masculino , Membrana Mucosa/patología , Omeprazol/administración & dosificación , Omeprazol/uso terapéutico , Ranitidina/administración & dosificación , Ranitidina/uso terapéutico
10.
J Hepatol ; 17(1): 81-5, 1993 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8445223

RESUMEN

Patients with liver disease frequently have impaired blood coagulation. The optimal method for liver biopsy in this situation is not established. To investigate this issue we randomised 117 patients with impaired blood coagulation, in whom liver biopsy was required, to receive either transjugular or plugged-percutaneous biopsy. Seventeen patients were excluded prior to biopsy and a protocol biopsy was performed in 100 patients (44 transjugular, 56 plugged-percutaneous). Liver tissue was obtained in 97 (42 transjugular, 55 plugged-percutaneous). Plugged-percutaneous liver biopsy was quicker and easier than transjugular liver biopsy and the biopsies obtained were significantly larger (12 +/- 5 mm vs. 6 +/- 4 mm; p < 0.001). However, 2 of 56 (3.5%) patients who received plugged-percutaneous biopsy had haemorrhage which required transfusion, while none of the 44 patients who received transjugular biopsy had haemorrhage (not significant). Both methods of liver biopsy were associated with a high success rate and a low incidence of complications. Plugged-percutaneous liver biopsy provides larger biopsies but may be associated with an increased risk of haemorrhage.


Asunto(s)
Biopsia/métodos , Trastornos de la Coagulación Sanguínea/patología , Hepatopatías/patología , Hígado/patología , Biopsia/efectos adversos , Trastornos de la Coagulación Sanguínea/sangre , Trastornos de la Coagulación Sanguínea/complicaciones , Femenino , Humanos , Cirrosis Hepática/sangre , Cirrosis Hepática/complicaciones , Cirrosis Hepática/patología , Hepatopatías/sangre , Hepatopatías/complicaciones , Masculino , Persona de Mediana Edad , Recuento de Plaquetas , Tiempo de Protrombina
11.
Arterioscler Thromb ; 12(4): 468-73, 1992 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1558838

RESUMEN

The solubilization and delivery of lipids in plasma rely on both forms of apolipoprotein B (apo B): apo B-100 and apo B-48. Apo B-48 is the translational product of apo B-100 mRNA that undergoes peritranscriptional conversion of C----U, replacing codon CAA (glutamine 2,153) with the inframe stop codon (UAA). We examined mRNA editing activity in the human and the rat by reverse transcription-polymerase chain reaction primer-extension analysis of intestine and liver total RNA. In rat intestine the percentage of apo B transcripts that undergo editing increases dramatically the day before birth (from approximately 1% to 80%), whereas the rat liver acquires an adult level of editing activity during the third postnatal week (rising from approximately 8% to 30%), when weaning is completed, bile acid composition matures, and plasma thyroid hormone levels peak. In contrast to the rat, the human intestine acquires adult levels of apo B mRNA editing relatively early in fetal development, rising from 10% at 10 weeks to approximately 80% by the end of the second trimester. Our results establish that apo B mRNA editing is 1) developmentally regulated in a tissue- and species-specific manner; 2) fully developed prenatally in both human and rat intestine, suggesting a crucial role of apo B-48 in mammalian fetal adaptation to extrauterine life; and 3) acquired early in human fetal intestine, implying a potential role for apo B-48 in prenatal lipid metabolism.


Asunto(s)
Apolipoproteínas B/genética , Regulación de la Expresión Génica , Intestinos/crecimiento & desarrollo , Hígado/crecimiento & desarrollo , ARN Mensajero/metabolismo , Animales , Animales Recién Nacidos , Apolipoproteína B-48 , Secuencia de Bases , Humanos , Lactante , Mucosa Intestinal/metabolismo , Intestinos/embriología , Hígado/embriología , Hígado/metabolismo , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Ratas , Ratas Endogámicas , Transcripción Genética
12.
Adv Exp Med Biol ; 285: 237-44, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1830448

RESUMEN

The elucidation of the structure and function of the plasma apolipoproteins has provided the unique opportunity to understand the physiological pathways for the transport and cellular metabolism of the plasma lipoproteins. The complexity of the individual density classes of plasma lipoproteins has been revealed by a detailed analysis of the apolipoprotein composition of the individual lipoprotein particles. In addition, the elucidation of the molecular defects in patients with dyslipoproteinemias has now permitted the understanding of the defects at the level of the apolipoprotein gene. The ability to define the genetic defect in individuals at risk for the development of premature cardiovascular disease provides the unique opportunity to now identify these individuals at an earlier age, and to initiate therapy to prevent the development of early heart disease.


Asunto(s)
Hiperlipoproteinemias/metabolismo , Lipoproteínas/metabolismo , Apolipoproteína A-I , Apolipoproteínas A/metabolismo , Apolipoproteínas B/metabolismo , Humanos , Hiperlipoproteinemias/genética , Lipoproteína(a) , Lipoproteínas/genética , Lipoproteínas HDL/metabolismo
13.
J Lipid Res ; 31(10): 1761-9, 1990 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-2079601

RESUMEN

Apolipoprotein B (apoB), an apolipoprotein associated with very low density lipoproteins and the atherogenic low density lipoproteins (LDL), directs the metabolism of lipoprotein particles in plasma by interacting with the LDL receptor. Utilizing human intestinal biopsy organ cultures, we have studied the synthesis of intestinal apoB in man. Intestinal organ cultures from normal adults (n = 6) were incubated in the presence of protease inhibitors in media supplemented with [35S]methionine. Media from these cultures were evaluated by sequential NaDodSO4 polyacrylamide gel electrophoresis, radioautography, and Western blot analyses, and intestinal biopsies were studied using immunohistochemistry. The relative abundance of apoB-100 and apoB-48 mRNA was assessed using reverse transcriptase-polymerase chain reaction followed by primer extension. Although apoB-48 was the principal isoprotein that was newly synthesized by intestinal organ cultures, apoB-100 was also synthesized and secreted by human intestinal organ cultures with 16 +/- 3% of the intestinal apoB mRNA coding for apoB-100. These results establish that apoB-100 is produced by the human intestine. The synthesis of the atherogenic apoB-100 by the intestine has pathophysiologic implications for the development of diet-induced atherosclerosis.


Asunto(s)
Apolipoproteínas B/biosíntesis , Mucosa Intestinal/metabolismo , Adulto , Apolipoproteína B-100 , Apolipoproteína B-48 , Apolipoproteínas B/genética , Secuencia de Bases , Western Blotting , Electroforesis en Gel de Poliacrilamida , Humanos , Inmunohistoquímica , Datos de Secuencia Molecular , Técnicas de Cultivo de Órganos , Inhibidores de Proteasas/metabolismo , ARN Mensajero/análisis , ARN Mensajero/genética
14.
J Clin Invest ; 85(1): 93-100, 1990 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2153155

RESUMEN

Generalized thyroid hormone resistance (GTHR) is a disorder of thyroid hormone action that we have previously shown to be tightly linked to one of the two thyroid hormone receptor genes, c-erbA beta, in a single kindred, A. We now show that in two other kindreds, B and D, with differing phenotypes, there is also linkage between c-erbA beta and GTHR. The combined maximum logarithm of the odds score for all three kindreds at a recombination fraction of 0 was 5.77. In vivo studies had shown a triiodothyronine (T3)-binding affinity abnormality in nuclear receptors of kindred A, and we therefore investigated the defect in c-erbA beta in this kindred by sequencing a major portion of the T3-binding domain in the 3'-region of fibroblast c-erbA beta cDNA and leukocyte c-erbA beta genomic DNA. A base substitution, cytosine to adenine, was found at cDNA position 1643 which altered the proline codon at position 448 to a histidine. By allelic-specific hybridization, this base substitution was found in only one allele of seven affected members, and not found in 10 unaffected members of kindred A, as expected for a dominant disease. Also, this altered base was not found in kindreds B or D, or in 92 random c-erbA beta alleles. These results and the fact that the mutation is predicted to alter the secondary structure of the crucial T3-binding domain of the c-erbA beta receptor suggest this mutation is an excellent candidate for the genetic cause of GTHR in kindred A. Different mutations in the c-erbA beta gene are likely responsible for the variant phenotypes of thyroid hormone resistance in kindreds B and D.


Asunto(s)
Mutación , Proteínas Proto-Oncogénicas/genética , Receptores de Hormona Tiroidea/genética , Enfermedades de la Tiroides/genética , Hormonas Tiroideas/uso terapéutico , Alelos , Secuencia de Bases , ADN/genética , Resistencia a Medicamentos/genética , Femenino , Ligamiento Genético , Humanos , Masculino , Datos de Secuencia Molecular , Hibridación de Ácido Nucleico , Linaje , Fenotipo , Proteínas Tirosina Quinasas/genética , Proto-Oncogenes , Enfermedades de la Tiroides/tratamiento farmacológico
15.
Blood ; 73(8): 2104-7, 1989 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-2567187

RESUMEN

A DNA polymorphism in the coding region of coagulation factor IX--potentially valuable for carrier detection, prenatal diagnosis, and population studies--was described in 1985. It had been discovered with monoclonal antibodies that distinguish between threonine and alanine as the 148th residue of the peptide. Its use as a diagnostic tool has been limited because threonine-containing factor IX (Malmö A) is dominant to alanine-containing factor IX (Malmö B) in immunoassays of plasma; therefore, detection of Malmö heterozygotes is not possible in all instances. A DNA method for recognizing all heterozygotes has been developed, but it also has limitations. We report the development of another DNA procedure based on amplification of the relevant DNA with the polymerase chain reaction (PCR). This method is quick, avoids the use of isotopes and x-ray film, and specifically identifies all the Malmö genotypes: hemizygotes, homozygotes, and heterozygotes. The procedure can be performed satisfactorily on small samples of blood (less than 1 mL) as suggested by Kogan et al (N Engl J Med 317:985, 1987). The method described is applicable to any genetic polymorphism that overlaps a restriction enzyme recognition site.


Asunto(s)
Factor IX/genética , Genotipo , Polimorfismo Genético , Polimorfismo de Longitud del Fragmento de Restricción , Secuencia de Bases , Exones , Femenino , Amplificación de Genes , Frecuencia de los Genes , Hemofilia B/genética , Humanos , Masculino , Datos de Secuencia Molecular , Linaje
16.
Nucleic Acids Res ; 17(2): 691-8, 1989 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-2464797

RESUMEN

Mature RNA transcripts from a single eukaryotic gene may contain different nucleotide sequences, ranging from alternately spliced exons to transcripts from separate alleles differing by only one base. Our laboratory and others have recently reported another class of RNA sequence differences, occurring in transcripts from the single copy apolipoprotein B (apoB) gene. A unique RNA editing mechanism allows expression of the CAA glutamine codon encoded by the apoB gene at nucleotide 6666, or terminates translation by the introduction of a premature UAA translational stop codon. In this study, we used the polymerase chain reaction (PCR) to amplify and characterize edited apoB RNA transcripts differing by a single nucleotide. Amplification and sequence analysis from small quantities of total RNA will facilitate the study of RNA editing and transcription in general.


Asunto(s)
Apolipoproteínas B/genética , Transcripción Genética , Animales , Composición de Base , Secuencia de Bases , Línea Celular , Clonación Molecular , ADN/síntesis química , ADN Polimerasa Dirigida por ADN , Amplificación de Genes , Humanos , Intestinos/análisis , Hígado/análisis , Masculino , Datos de Secuencia Molecular , ARN/aislamiento & purificación , Conejos , Ratas , Ratas Endogámicas , Polimerasa Taq
17.
Proc Natl Acad Sci U S A ; 86(2): 500-4, 1989 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2911593

RESUMEN

Two B apolipoproteins (apo) are present in human plasma, designated apoB-100 and apoB-48, and represent translational products from mature apoB mRNAs that differ by a single base. Either the glutamine codon encoded by the single-copy apoB gene at nucleotide 6666 is transcribed and translated to produce apoB-100 or an RNA-editing mechanism substitutes a uracil for cytosine, altering this glutamine codon (CAA) to a stop codon (UAA), prematurely terminating translation to produce apoB-48. In the present report, editing of rat apoB transcripts was evaluated by amplification of RNA with the polymerase chain reaction by use of primers based on the apoB cDNA cloned from a rat liver cDNA library. The combined results of this study show that (i) a single copy of the apoB gene exists in the rat; (ii) the rat apoB gene encodes only the glutamine codon for the synthesis of apoB of higher molecular weight (apoBH); (iii) rat apoB transcripts undergo RNA editing; (iv) apoBH and apoB of lower molecular weight (apoBL) in the rat represent structural equivalents of apoB-100 and apoB-48 in humans, respectively; (v) RNA editing occurs in both the liver and intestine of the rat; (vi) rat hepatic apoB RNA is more extensively edited than is human hepatic apoB RNA, which is consistent with the marked increase in apoBL secretion by the rat liver when compared with human; and (vii) the definitive identification of apoBH mRNA as well as apoBL mRNA in the rat intestine provides a mechanism for the biosynthesis of both apoBH and apoBL by the rat intestine.


Asunto(s)
Apolipoproteínas B/genética , Intestinos/análisis , Hígado/análisis , ARN Mensajero/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Codón/genética , ADN/genética , Electroforesis en Gel de Agar , Amplificación de Genes , Humanos , Masculino , Datos de Secuencia Molecular , Hibridación de Ácido Nucleico , ARN Mensajero/biosíntesis , Conejos , Ratas , Ratas Endogámicas , Mapeo Restrictivo , Homología de Secuencia de Ácido Nucleico
18.
Proc Natl Acad Sci U S A ; 85(16): 5804-8, 1988 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2901090

RESUMEN

The nucleotide and predicted amino acid sequences of two variant cDNAs [rat brain thyroid hormone receptor (rTR alpha) vI and vII], isolated from a rat brain cDNA library by using the Pst I fragment of v-erbA, showed virtual identity with the rat brain thyroid hormone receptor (rTR alpha) [Thompson, C. C., Weinberger, C., Lebo, R. & Evans, R. M. (1987) Science 237, 1610-1614] in the putative DNA binding domain and in the first 180 amino acids of the hormone binding domain but no similarity except for 5 amino acids at the extreme 3' end. Isolation and sequencing of the 3' end of the gene coding for rTR alpha, vI and vII mRNAs revealed that the 3' heterogeneity is due to alternative splicing of the primary transcripts of the same gene. RNA transfer blot analyses with probes unique to rTR alpha, rTR alpha vI, and rTR alpha vII showed that only the variant mRNAs are abundantly expressed in rat brain, contrary to the previously reported high-level expression of rTR alpha. Since in vitro translation products of rTR alpha vI and rTR alpha vII did not bind thyroid hormones specifically, our findings explain the discrepancy between the reported abundance of the receptor mRNA and the low receptor levels determined by ligand binding studies in rat brain. These variant mRNAs are also expressed in kidney, heart, spleen, and liver, albeit at lower levels. The presence of an intact DNA binding domain in rTR alpha vI and rTR alpha vII suggests that the variants might have modulating functions in thyroid hormone action.


Asunto(s)
Proteínas Proto-Oncogénicas/genética , Receptores de Hormona Tiroidea/genética , Hormonas Tiroideas/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , ADN/análisis , ADN/metabolismo , Datos de Secuencia Molecular , Biosíntesis de Proteínas , Proteínas Proto-Oncogénicas/análisis , Empalme del ARN , ARN Mensajero/análisis , Ratas , Receptores de Hormona Tiroidea/análisis
19.
Mol Cell Biol ; 8(8): 3542-5, 1988 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3211151

RESUMEN

We have characterized sequences of genomic DNA 5' to the coding region of the rat malic enzyme gene. This sequence possesses neither TATA nor CCAAT sequences in their usual positions but is rich in GC residues. Sequences similar to those found in the regulatory regions of other genes are discussed. Deletion analyses have revealed that sequences +1 to -41 are sufficient to initiate expression, although inclusion of information up to -177 is necessary for maximal promoter activity.


Asunto(s)
Genes , Malato Deshidrogenasa/genética , Regiones Promotoras Genéticas , Animales , Secuencia de Bases , Línea Celular , Hígado/enzimología , Neoplasias Hepáticas Experimentales/enzimología , Datos de Secuencia Molecular , Ratas , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA